Finance

Lists
603079:SHA
Zhejiang Shengda Bio-pharm Co Ltd
CNÂ¥12.36
-2.68%
(-0.34) 1D
Sep 11, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603079...
Open
CNÂ¥12.73
High
CNÂ¥12.79
Low
CNÂ¥12.18
Mkt. cap
2.40B
Avg. vol.
9.84M
Volume
4.60M
Dividend
0.81%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jul 1, 2026
P/E ratio
51.19
52-wk high
CNÂ¥22.00
52-wk low
CNÂ¥9.94
EPS
CNÂ¥0.24
Shares outstanding
112.00M
No. of employees
1K
Open
CNÂ¥12.73
High
CNÂ¥12.79
Low
CNÂ¥12.18
Mkt. cap
2.40B
Avg. vol.
9.84M
Volume
4.60M
Dividend
0.81%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jul 1, 2026
P/E ratio
51.19
52-wk high
CNÂ¥22.00
52-wk low
CNÂ¥9.94
EPS
CNÂ¥0.24
Shares outstanding
112.00M
No. of employees
1K
About Zhejiang Shengda Bio-pharm Co Ltd
CEO-
Employees1.08K
FoundedFeb 8, 1999
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
203.23M
223.25M
189.22M
199.84M
Cost of goods sold
144.50M
175.36M
136.99M
143.63M
Cost of revenue
144.50M
175.36M
136.99M
143.63M
Research and development expenses
10.16M
18.11M
10.09M
13.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.53M
22.59M
20.29M
22.44M
Operating expense
28.59M
48.77M
31.77M
38.45M
Total operating expenses
173.09M
224.13M
168.75M
182.08M
Operating income
30.14M
-879.22K
20.46M
17.76M
Other non operating income
86.11K
283.41K
-3.83M
-3.27M
EBT including unusual items
27.74M
8.03M
18.58M
13.30M
EBT excluding unusual items
31.07M
-279.90K
19.37M
13.91M
Income tax expense
4.32M
-2.51M
3.27M
4.09M
Effective tax rate
15.57%
-31.26%
17.59%
30.77%
Other operating expenses
264.36K
7.99M
1.54M
2.16M
Net income
21.71M
8.82M
13.17M
7.35M
Net profit margin
10.68%
3.95%
6.96%
3.68%
Earnings per share
-
-
-
-
Interest and investment income
1.09M
2.80M
2.86M
115.42K
Interest expense
-250.83K
-45.11K
-115.42K
-698.57K
Net interest expenses
843.82K
2.75M
2.74M
-583.15K
Depreciation and amortization charges
-
-
-
-
EBITDA
48.66M
17.98M
39.32M
38.90M
Gain or loss from assets sale
-
477.31K
-
563.49K
AI content may include mistakes. Learn more
Google apps